Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic.
Schattenberg, Jörn M
Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. [electronic resource] - Current opinion in lipidology Dec 2011 - 479-88 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
1473-6535
10.1097/MOL.0b013e32834c7cfc doi
Animals
Anti-Inflammatory Agents--therapeutic use
Bile Acids and Salts--therapeutic use
Diet, Reducing
Epidemics
Fatty Liver--epidemiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypoglycemic Agents--therapeutic use
Non-alcoholic Fatty Liver Disease
Obesity--drug therapy
Randomized Controlled Trials as Topic
Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. [electronic resource] - Current opinion in lipidology Dec 2011 - 479-88 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
1473-6535
10.1097/MOL.0b013e32834c7cfc doi
Animals
Anti-Inflammatory Agents--therapeutic use
Bile Acids and Salts--therapeutic use
Diet, Reducing
Epidemics
Fatty Liver--epidemiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypoglycemic Agents--therapeutic use
Non-alcoholic Fatty Liver Disease
Obesity--drug therapy
Randomized Controlled Trials as Topic